News Announcement

Supriya Lifescience: Board Meeting Outcome for Outcome Of Board Meeting Held On November 12 2025

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its Meeting held on Wednesday November 12 2025 inter-alia considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations 2015.The Meeting of the Board of Directors of the Company commenced at 03:00 p.m. and concluded at 03.30 p.m.Kindly take the above information on your records.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month